"
Membrane Proteins as Potential Colon Cancer Biomarkers: Verification of 4 Candidates from a Secretome Dataset"
written by Sum-Fu Chiang, Ming-Hung Tsai, Reiping Tang, Ling-Ling Hsieh, Jy-Ming Chiang, Chien-Yuh Yeh, Pao-Shiu Hsieh, Wen-Sy Tsai, Ya-Ping Liu, Ying Liang, Jinn-Shiun Chen, Jau-Song Yu,
published by
Surgical Science,
Vol.5 No.10, 2014
has been cited by the following article(s):
|
[1]
|
Risk scoring based on DNA methylation-driven related DEGs for colorectal cancer prognosis with systematic insights
|
|
Soares, N Ahituv, KC Wong - Life Sciences,
2023 |
|
|
|
|
[2]
|
The role of the tetraspanin6 (TSPAN6) in regulating the immune microenvironment in inflammatory breast cancer (IBC)
|
|
2023 |
|
|
|
|
[3]
|
Extracellular Vesicle Membrane Protein Profiling and Targeted Mass Spectrometry Unveil CD59 and Tetraspanin 9 as Novel Plasma Biomarkers for Detection …
|
|
Cancers,
2022 |
|
|
|
|
[4]
|
Extracellular vesicle membrane protein profiling and targeted mass spectrometry unveil CD59 and tetraspanin 9 as novel plasma biomarkers for detection of …
|
|
Cancers,
2022 |
|
|
|
|
[5]
|
DNMT3B modulates the expression of cancer-related genes and downregulates the expression of the gene VAV3 via methylation
|
|
American journal of cancer research,
2017 |
|
|
|
|
[6]
|
Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome‐Based Verification Study
|
|
Disease …,
2015 |
|
|
|
|
[7]
|
Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study
|
|
Disease Markers,
2015 |
|
|
|
|
[8]
|
Recursive Random Lasso (RRLasso) for Identifying Anti-Cancer Drug Targets
|
|
PloS one,
2015 |
|
|
|
|
[9]
|
Up-regulation of AKAP13 and MAGT1 on cytoplasmic membrane in progressive hepatocellular carcinoma: a novel target for prognosis
|
|
International journal of clinical and experimental pathology,
2015 |
|
|
|
|
[10]
|
Up-regulation of AKAP13 and MAGT1 on cytoplasmic membrane in progressive hepatocellular carcinoma: a novel target for prognosis.
|
|
International Journal of Clinical and Experimental Pathology,
2014 |
|
|
|
|
[1]
|
Anionic Surfactant-Triggered Excimer Emission from Dipyrene-Based Amphiphilic Dyes for Wash-Free Cell Membrane Imaging
Journal of Fluorescence,
2025
DOI:10.1007/s10895-025-04304-z
|
|
|
|
|
[2]
|
Classifying the tumor immune microenvironment in cervical cancer based on nuclear cytoplasmic consistent genes
Scientific Reports,
2025
DOI:10.1038/s41598-025-26740-4
|
|
|
|
|
[3]
|
Risk scoring based on DNA methylation-driven related DEGs for colorectal cancer prognosis with systematic insights
Life Sciences,
2023
DOI:10.1016/j.lfs.2023.121413
|
|
|
|
|
[4]
|
Extracellular Vesicle Membrane Protein Profiling and Targeted Mass Spectrometry Unveil CD59 and Tetraspanin 9 as Novel Plasma Biomarkers for Detection of Colorectal Cancer
Cancers,
2022
DOI:10.3390/cancers15010177
|
|
|
|
|
[5]
|
Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study
Disease Markers,
2015
DOI:10.1155/2015/874054
|
|
|
|
|
[6]
|
Recursive Random Lasso (RRLasso) for Identifying Anti-Cancer Drug Targets
PLOS ONE,
2015
DOI:10.1371/journal.pone.0141869
|
|
|
|